According to a new report published by UnivDatos Markets Insights, the monoclonal antibodies market was valued at USD 180 billion in 2021 & is expected to grow at a CAGR of 9% from 2022-2028. The analysis has been segmented into Source (Chimeric, Human, Humanized, and Murine); Indication (Oncology, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, and Others); End User...